SF
TCRT icon

Synovus Financial’s Alaunos Therapeutics TCRT Stock Holding History

Synovus Financial’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-273
Closed -$2.9K – 870
2023
Q4 		$2.9K Hold
273
– – ﹤0.01% 821
2023
Q3 		$5.4K Hold
273
– – ﹤0.01% 836
2023
Q2 		$20.9K Sell
273
-5
-2% -$404 ﹤0.01% 835
2023
Q1 		$26.3K Hold
278
– – ﹤0.01% 819
2022
Q4 		$27.1K Buy
278
+6
+2% +$870 ﹤0.01% 852
2022
Q3 		$70K Buy
272
+52
+24% +$15.1K ﹤0.01% 830
2022
Q2 		$41K Sell
220
-253
-53% -$24.2K ﹤0.01% 834
2022
Q1 		$46K Buy
473
+21
+5% +$2.69K ﹤0.01% 837
2021
Q4 		$74K Hold
452
– – ﹤0.01% 848
2021
Q3 		$124K Buy
452
+267
+144% +$81.7K ﹤0.01% 824
2021
Q2 		$73K Hold
185
– – ﹤0.01% 828
2021
Q1 		$100K Hold
185
– – ﹤0.01% 739
2020
Q4 		$70K Hold
185
– – ﹤0.01% 753
2020
Q3 		$70K Buy
+185
New +$81.7K ﹤0.01% 697
2018
Q2 		– Sell
-16
Closed -$9K – 1287
2018
Q1 		$9K Buy
+16
New +$9.97K ﹤0.01% 1057
2017
Q2 		– Sell
-16
Closed -$15K – 1074
2017
Q1 		$15K Hold
16
– – ﹤0.01% 906
2016
Q4 		$13K Buy
+16
New +$14.4K ﹤0.01% 897

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Synovus Financial's TCRT Position: Q1 2024 in Review

Synovus Financial sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 273 shares — an estimated $2.9K sold.

Synovus Financial first reported a position in TCRT in Q4 2016 and held it in 17 quarters. The position peaked at $124K in Q3 2021. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.

  • Synovus Financial reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Synovus Financial sold 273 Alaunos Therapeutics shares in Q1 2024, an estimated $2.9K.
  • Synovus Financial first reported a position in Alaunos Therapeutics in Q4 2016 and held it in 17 quarters.
  • Synovus Financial's Alaunos Therapeutics position peaked at $124K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.

Based on Synovus Financial's 13F filing for Q1 2024, filed 14 May 2024.